Continuous Glucose Monitoring Devices Market to Reach US$ 10.72 Billion by 2033 at 8.1% CAGR; North America Leads with 40% Share - Key Players: Dexcom, Inc., Abbott Laboratories, Medtronic Plc

The Continuous Glucose Monitoring Devices Market was valued at US$ 5.24 billion in 2023 and reached US$ 5.61 billion in 2024. The market is projected to reach US$ 10.72 billion by 2033, growing at a CAGR of 8.1 percent during the forecast period 2025 to 2033. Growth is driven by the rising global prevalence of diabetes, increasing awareness about real time glucose tracking, and growing demand for minimally invasive and continuous diabetes management solutions.

Continuous glucose monitoring devices are wearable systems that provide real time glucose readings and trend insights, enabling better insulin dosing and lifestyle management. Advancements such as extended sensor wear, smartphone connectivity, and integration with insulin delivery systems are enhancing patient adherence and outcomes. Strong innovation by companies such as Dexcom and Abbott Laboratories, along with regulatory approvals from the U.S. Food and Drug Administration, continue to support global market expansion.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/continuous-glucose-monitoring-devices-market?sai-v

The Continuous Glucose Monitoring Devices Market centers on wearable sensor based systems that provide real time glucose tracking, enabling better diabetes management, improved glycemic control, and proactive health decision making.

Key Developments
✅ February 2026: In North America and Europe, Dexcom launched an upgraded continuous glucose monitoring (CGM) system with enhanced sensor accuracy, extended wear duration, and integrated predictive glucose analytics, and expanded reimbursement support partnerships with major insurers.

✅ January 2026: In Asia Pacific, Abbott Laboratories introduced its next-generation Freestyle Libre CGM platform featuring real-time alerts and extended wear capabilities, and secured expanded distribution agreements across India, China, and Southeast Asian markets.

✅ December 2025: In Europe, Medtronic advanced its Guardian Connect CGM offering with improved smartphone integration and automated insulin dosing compatibility, and strengthened product support programs for endocrinology clinics.

✅ November 2025: In United States, Senseonics expanded its Eversense implantable CGM system by gaining additional clinical endorsements and increasing availability through national diabetes care networks.

✅ October 2025: In Global Markets, Tandem Diabetes Care integrated CGM connectivity features across its insulin pump platforms and expanded interoperability with leading glucose monitoring ecosystems.

✅ September 2025: In Latin America, Roche Diabetes Care enhanced local access to CGM devices by strengthening partnerships with regional distributors and diabetes care providers to support growing demand for real-time glucose monitoring solutions.

Key Players

Abbott Laboratories | Dexcom, Inc. | Medtronic Plc | Ascensia Diabetes Care Holdings AG | F. Hoffmann-La Roche Ltd. | iHealth Labs Inc. | Ypsomed AG | Medtrum Technologies Inc. | Menarini Diagnostics S.r.l. | Nemaura Medical Inc. | Senseonics Holdings, Inc. | Glucovation, Inc. | Afon Technology Ltd. | Signos Inc. | Others

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=continuous-glucose-monitoring-devices-market?sai-v
(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Market Drivers
- The increasing prevalence of diabetes worldwide is driving demand for advanced glucose monitoring solutions.

- Growing patient preference for real-time glucose tracking to improve glycemic control and reduce complications.

- Rising adoption of continuous glucose monitoring (CGM) devices among type 1 and type 2 diabetic patients is supported by clinical evidence of better outcomes.

- Technological advancements in sensor accuracy, wearability, and connectivity are enhancing user comfort and device functionality.

- Integration of CGM platforms with mobile applications, insulin pumps, and digital health ecosystems for remote care and data-driven management.

- Supportive reimbursement policies and expanding insurance coverage lower financial barriers to CGM adoption.

- Growing awareness among healthcare providers and patients about the benefits of continuous monitoring over traditional finger-stick testing.

Industry Developments
- Launch of next-generation CGM systems with improved sensor lifetime, enhanced accuracy, and seamless smartphone integration.

- Strategic partnerships between device manufacturers, digital health platform providers, and healthcare systems to expand monitoring networks.

- Development of interoperable CGM solutions that integrate with insulin delivery systems and glucose management apps.

- Investments in advanced algorithms, predictive analytics, and AI-enabled alerts that support personalized diabetes care.

- Expansion of service, training, and support offerings to improve patient adherence and clinician utilization.

- Introduction of smaller, wearable, and minimally invasive CGM devices designed for enhanced comfort and long-term use.

Regional Insights
North America - 40% share: "Driven by high diabetes prevalence, strong adoption of digital health technologies, established reimbursement frameworks, and early uptake of advanced CGM systems in the United States and Canada."

Europe - 27% share: "Supported by robust healthcare systems, growing awareness of continuous monitoring benefits, and increasing integration of CGM into diabetes care pathways across major European markets."

Asia Pacific - 26% share: "Fueled by rising diabetes burden, expanding healthcare access, and increasing investments in CGM technology adoption in China, India, Japan, and Southeast Asia."

Latin America - 5% share: "Boosted by improving healthcare infrastructure, greater diabetes screening, and gradual uptake of continuous glucose monitoring solutions."

Middle East & Africa - 2% share: "Driven by emerging diabetes care initiatives, increasing healthcare investments, and growing awareness of real-time glucose monitoring benefits."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/continuous-glucose-monitoring-devices-market?sai-v

Key Segments
By Component
Sensors represent the core component, continuously measuring interstitial glucose levels and transmitting real time data. Transmitters attach to sensors and send glucose readings wirelessly to compatible devices. Receivers include dedicated monitoring devices or integrated display units that allow users to track glucose trends and alerts.

By Connectivity
Bluetooth connectivity dominates the segment due to low power consumption, seamless smartphone integration, and real time data sharing. Wi Fi connectivity supports cloud based data storage, remote monitoring, and integration with digital health platforms.

By Application
Type 1 diabetes accounts for a major share, as continuous glucose monitoring plays a critical role in intensive insulin management. Type 2 diabetes adoption is increasing with growing emphasis on proactive glucose control. Gestational diabetes is a rising segment, supporting close monitoring during pregnancy. Prediabetes monitoring is gaining attention for early intervention and lifestyle management.

By End User
Hospitals and clinics represent a significant segment, utilizing continuous glucose monitoring for inpatient care and diabetes management programs. Homecare settings dominate long term usage, driven by patient preference for self monitoring and remote physician oversight. Diagnostic centers adopt these systems for specialized diabetes evaluation and follow up. Other end users include research institutes and ambulatory care facilities supporting clinical studies and outpatient monitoring.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.